sollistx.comHealthcareFounded: 2017Funding to Date: $49.89MM
Sollis Therapeutics is a clinical-stage pharmaceutical company developing novel interventional non-steroid, non-opioid analgesics.
For more details on financing and valuation for Sollis Therapeutics, register or login.
View Enterprise Value for Sollis Therapeutics.
To read this article and more news on Sollis Therapeutics, register or login.